Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II
Mathieu Gaudreault, Nicholas Hardcastle, Price Jackson, Lachlan McIntosh, Braden Higgs, David Pryor, Mark Sidhom, Rachael Dykyj, Alisha Moore, Tomas Kron, Shankar Siva
Topics & Concepts
SABR volatility modelRenal functionRenal cell carcinomaUrologyKidneyFunction (biology)Internal medicineMedicineEndocrinologyBiologyMathematicsCell biologyVolatility (finance)Stochastic volatilityEconometricsRenal cell carcinoma treatmentHepatocellular Carcinoma Treatment and PrognosisKidney Stones and Urolithiasis Treatments